An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis

Overview

To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis

Full Title of Study: “An Open-Label Study of the Effect of C-KAD Ophthalmic Solution on Asteroid Hyalosis”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2009

Interventions

  • Drug: C-KAD Ophthalmic Solution
    • 4 drops applied daily for 180 days

Arms, Groups and Cohorts

  • Experimental: C-KAD Ophthalmic Solution

Clinical Trial Outcome Measures

Primary Measures

  • Reduction in the number of asteroid bodies
    • Time Frame: 180

Participating in This Clinical Trial

Inclusion Criteria

  • Presence of asteroid hyalosis Exclusion Criteria:

  • Active ocular infection – Glaucoma – Ocular hypertension – Ocular inflammatory disorders

Gender Eligibility: All

Minimum Age: 21 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Chakshu Research, Inc.
  • Provider of Information About this Clinical Study
    • Ellen Hoogeveen /Associate Director, Clinical & Regulatory Affairs, Chakshu Research, Inc.
  • Overall Official(s)
    • Ira Wong, MD, Study Director, Chakshu Research, Inc.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.